tradingkey.logo

Boston Scientific Corp

BSX

102.360USD

+1.060+1.05%
Fechamento 06/23, 16:00ETCotações atrasadas em 15 min
151.41BValor de mercado
81.71P/L TTM

Boston Scientific Corp

102.360

+1.060+1.05%
Mais detalhes de Boston Scientific Corp Empresa
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Informações da empresa
Código da empresaBSX
Nome da EmpresaBoston Scientific Corp
Data de listagemMay 19, 1992
Fundado em1979
CEOMr. Michael F. (Mike) Mahoney
Número de funcionários53000
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 19
Endereço300 Boston Scientific Way
CidadeMARLBOROUGH
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal01752-1234
Telefone15086834000
Sitehttps://www.bostonscientific.com/en-US/Home.html
Código da empresaBSX
Data de listagemMay 19, 1992
Fundado em1979
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-3.25%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
37.02K
+5.96%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
31.37K
-13.33%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+58.67%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
4.98K
+71.73%
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Executive Vice President, Group President, MedSurg and Asia Pacific
Executive Vice President, Group President, MedSurg and Asia Pacific
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
Ms. Meghan Scanlon
Ms. Meghan Scanlon
Senior Vice President and President - Urology
Senior Vice President and President - Urology
--
--
Mr. David Scott (Dave) Wichmann
Mr. David Scott (Dave) Wichmann
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-3.25%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
37.02K
+5.96%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
31.37K
-13.33%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+58.67%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
4.98K
+71.73%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de abr
Moeda: USDAtualizado em: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Endoscopy
2.69B
16.04%
Interventional Cardiology Therapies
2.65B
15.79%
Peripheral Interventions
2.41B
14.39%
Cardiac Rhythm Management
2.28B
13.61%
Urology
2.20B
13.14%
Other
4.53B
27.03%
Por RegiãoUSD
Nome
Receita
Proporção
United States
10.21B
60.97%
EMEA (Europe, Middle East and Africa)
3.23B
19.28%
Asia Pacific
2.69B
16.04%
Latin America and Canada
624.00M
3.73%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Endoscopy
2.69B
16.04%
Interventional Cardiology Therapies
2.65B
15.79%
Peripheral Interventions
2.41B
14.39%
Cardiac Rhythm Management
2.28B
13.61%
Urology
2.20B
13.14%
Other
4.53B
27.03%
Distribuição de ações
Atualizado em: qua, 14 de mai
Atualizado em: qua, 14 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.05%
Fidelity Management & Research Company LLC
7.94%
BlackRock Institutional Trust Company, N.A.
5.26%
State Street Global Advisors (US)
4.36%
PRIMECAP Management Company
2.47%
Other
70.92%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.05%
Fidelity Management & Research Company LLC
7.94%
BlackRock Institutional Trust Company, N.A.
5.26%
State Street Global Advisors (US)
4.36%
PRIMECAP Management Company
2.47%
Other
70.92%
Tipos de investidores
Investidores
Proporção
Investment Advisor
43.45%
Investment Advisor/Hedge Fund
36.88%
Hedge Fund
3.98%
Pension Fund
2.84%
Research Firm
2.45%
Bank and Trust
1.70%
Sovereign Wealth Fund
1.55%
Private Equity
0.20%
Insurance Company
0.19%
Other
6.76%
Participação acionária institucional
Atualizado em: dom, 19 de jan
Atualizado em: dom, 19 de jan
Var. %
Ações detidas
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
2650
1.38B
93.37%
-1.15M
2024Q4
2559
1.38B
93.61%
+1.09M
2024Q3
2417
1.37B
92.76%
-24.32M
2024Q2
2341
1.37B
93.29%
-18.17M
2024Q1
2227
1.37B
93.23%
-40.14M
2023Q4
2171
1.39B
94.95%
-25.34M
2023Q3
2110
1.39B
95.17%
-6.29M
2023Q2
2081
1.38B
95.67%
-15.63M
2023Q1
2012
1.36B
94.85%
-23.81M
2022Q4
1993
1.36B
94.66%
-54.91M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
132.25M
8.94%
+1.62M
+1.24%
Dec 31, 2024
Fidelity Management & Research Company LLC
121.20M
8.19%
-2.05M
-1.66%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
76.72M
5.19%
+7.50M
+10.84%
Dec 31, 2024
State Street Global Advisors (US)
63.96M
4.32%
+1.12M
+1.78%
Dec 31, 2024
PRIMECAP Management Company
36.93M
2.5%
-896.83K
-2.37%
Dec 31, 2024
Wellington Management Company, LLP
36.17M
2.45%
+3.34M
+10.19%
Dec 31, 2024
Geode Capital Management, L.L.C.
30.63M
2.07%
+1.04M
+3.52%
Dec 31, 2024
Capital World Investors
27.90M
1.89%
+6.22M
+28.67%
Dec 31, 2024
Managed Account Advisors LLC
17.69M
1.2%
+122.78K
+0.70%
Dec 31, 2024
The Bollard Group, LLC
20.73M
1.4%
-510.32K
-2.40%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Atualizado em: sex, 6 de jun
Atualizado em: sex, 6 de jun
Nome
Proporção
iShares U.S. Medical Devices ETF
12.31%
Goldman Sachs Future Health Care Equity ETF
8.38%
NYLI Healthy Hearts ETF
5.45%
JPMorgan Healthcare Leaders ETF
4.69%
iShares Health Innovation Active ETF
4.66%
Invesco Dorsey Wright Healthcare Momentum ETF
3.7%
iShares Large Cap Active ETF
3.47%
Congress Large Cap Growth ETF
3.24%
Global X Aging Population ETF
3.13%
Health Care Select Sector SPDR Fund
3.04%
Ver Mais
iShares U.S. Medical Devices ETF
Proporção12.31%
Goldman Sachs Future Health Care Equity ETF
Proporção8.38%
NYLI Healthy Hearts ETF
Proporção5.45%
JPMorgan Healthcare Leaders ETF
Proporção4.69%
iShares Health Innovation Active ETF
Proporção4.66%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção3.7%
iShares Large Cap Active ETF
Proporção3.47%
Congress Large Cap Growth ETF
Proporção3.24%
Global X Aging Population ETF
Proporção3.13%
Health Care Select Sector SPDR Fund
Proporção3.04%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI